Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Mimedx (MDXG) Change in Acquisitions & Divestments (2016 - 2021)

Mimedx's Change in Acquisitions & Divestments history spans 6 years, with the latest figure at $30000.0 for Q3 2021.

On a quarterly basis, Change in Acquisitions & Divestments changed N/A to $30000.0 in Q3 2021 year-over-year; TTM through Jun 2022 was $30000.0, a 33.33% decrease, with the full-year FY2021 number at $75000.0, changed N/A from a year prior.
Change in Acquisitions & Divestments hit $30000.0 in Q3 2021 for Mimedx, roughly flat from $30000.0 in the prior quarter.
Over the last five years, Change in Acquisitions & Divestments for MDXG hit a ceiling of $2.3 million in Q3 2019 and a floor of $15000.0 in Q1 2021.
Historically, Change in Acquisitions & Divestments has averaged $595833.3 across 3 years, with a median of $209500.0 in 2019.